235 related articles for article (PubMed ID: 22654847)
1. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
Irwin RW; Wang JM; Chen S; Brinton RD
Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
[TBL] [Abstract][Full Text] [Related]
2. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
[TBL] [Abstract][Full Text] [Related]
3. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
Irwin RW; Brinton RD
Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
[TBL] [Abstract][Full Text] [Related]
5. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
[TBL] [Abstract][Full Text] [Related]
8. Regenerative potential of allopregnanolone.
Wang JM; Liu L; Irwin RW; Chen S; Brinton RD
Brain Res Rev; 2008 Mar; 57(2):398-409. PubMed ID: 17931704
[TBL] [Abstract][Full Text] [Related]
9. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
[TBL] [Abstract][Full Text] [Related]
11. Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Irwin RW; Solinsky CM; Brinton RD
Front Cell Neurosci; 2014; 8():203. PubMed ID: 25126056
[TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.
Wang JM; Brinton RD
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S11. PubMed ID: 19090984
[TBL] [Abstract][Full Text] [Related]
13. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
Sun C; Ou X; Farley JM; Stockmeier C; Bigler S; Brinton RD; Wang JM
Curr Alzheimer Res; 2012 May; 9(4):473-80. PubMed ID: 22272610
[TBL] [Abstract][Full Text] [Related]
14. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
[TBL] [Abstract][Full Text] [Related]
15. GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?
Bengtsson SKS; Bäckström T; Brinton R; Irwin RW; Johansson M; Sjöstedt J; Wang MD
Neurobiol Stress; 2020 May; 12():100206. PubMed ID: 31921942
[TBL] [Abstract][Full Text] [Related]
16. Allopregnanolone attenuates Aβ25-35-induced neurotoxicity in PC12 cells by reducing oxidative stress.
Qian X; Cao H; Ma Q; Wang Q; He W; Qin P; Ji B; Yuan K; Yang F; Liu X; Lian Q; Li J
Int J Clin Exp Med; 2015; 8(8):13610-5. PubMed ID: 26550302
[TBL] [Abstract][Full Text] [Related]
17. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease.
Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA
Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631
[TBL] [Abstract][Full Text] [Related]
18. Allopregnanolone increases mature excitatory synapses along dendrites via protein kinase A signaling.
Shimizu H; Ishizuka Y; Yamazaki H; Shirao T
Neuroscience; 2015 Oct; 305():139-45. PubMed ID: 26241343
[TBL] [Abstract][Full Text] [Related]
19. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
Wang T; Yao J; Chen S; Mao Z; Brinton RD
Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
